8-K/A

REXAHN PHARMACEUTICALS 8-K A 2-19-2009

Company: Opus Genetics, Inc.
Filed: March 2, 2009
Period of Report: February 19, 2009
Accession Number: 0001140361-09-005416

View Document ↗ View on SEC.gov ↗